The Potential Role of Baseline FT3/FT4 Ratio as a Prognostic Biomarker for Patients With Ischemic Non-Obstructive Coronary Artery Disease. Wu F, Zheng X, Hong L, Wu Q, et al. Clin Cardiol 2026;49:e70331.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu F, Zheng X, Hong L, Wu Q, et al. The Potential Role of Baseline FT3/FT4 Ratio as a Prognostic Biomarker for Patients With Ischemic Non-Obstructive Coronary Artery Disease. Clin Cardiol 2026;49:e70331.
PMID: 42029333